Parametric Portfolio Associates LLC Boosts Position in Smith & Nephew plc (NYSE:SNN)

Share on StockTwits

Parametric Portfolio Associates LLC grew its stake in shares of Smith & Nephew plc (NYSE:SNN) by 4.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 818,149 shares of the medical equipment provider’s stock after buying an additional 34,289 shares during the period. Parametric Portfolio Associates LLC’s holdings in Smith & Nephew were worth $39,378,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC boosted its position in shares of Smith & Nephew by 640.8% in the first quarter. FMR LLC now owns 1,341,034 shares of the medical equipment provider’s stock valued at $53,788,000 after acquiring an additional 1,160,015 shares during the period. Confluence Investment Management LLC boosted its holdings in Smith & Nephew by 2.6% in the 2nd quarter. Confluence Investment Management LLC now owns 13,229 shares of the medical equipment provider’s stock valued at $576,000 after purchasing an additional 335 shares during the period. Wetherby Asset Management Inc. boosted its holdings in Smith & Nephew by 4.4% in the 2nd quarter. Wetherby Asset Management Inc. now owns 18,443 shares of the medical equipment provider’s stock valued at $803,000 after purchasing an additional 776 shares during the period. Steward Partners Investment Advisory LLC purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at $126,000. Finally, Advisor Partners LLC purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at $235,000. Hedge funds and other institutional investors own 8.91% of the company’s stock.

Shares of NYSE:SNN opened at $44.47 on Tuesday. The company’s fifty day moving average price is $44.19 and its 200-day moving average price is $44.82. The firm has a market capitalization of $19.58 billion, a price-to-earnings ratio of 22.01, a PEG ratio of 4.01 and a beta of 0.23. Smith & Nephew plc has a one year low of $35.39 and a one year high of $48.93. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.00 and a quick ratio of 0.96.

A number of brokerages recently issued reports on SNN. Sanford C. Bernstein initiated coverage on Smith & Nephew in a research report on Tuesday, November 12th. They issued an “outperform” rating on the stock. Zacks Investment Research upgraded Smith & Nephew from a “sell” rating to a “hold” rating in a research report on Tuesday, November 26th. ValuEngine lowered Smith & Nephew from a “hold” rating to a “sell” rating in a research note on Wednesday, October 2nd. Finally, Citigroup assumed coverage on Smith & Nephew in a research note on Thursday, November 21st. They issued a “buy” rating on the stock. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. Smith & Nephew has a consensus rating of “Hold” and a consensus target price of $27.50.

Smith & Nephew Profile

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Further Reading: Why are percentage decliners important?

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.